Birth to Three - Cavity Free
Launched by UNIVERSITY OF IOWA · Feb 23, 2023
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
The "Birth to Three - Cavity Free" clinical trial is studying ways to prevent early childhood caries (ECC), which is a common tooth decay problem in young children, especially among those from low-income and minority families. The research aims to find effective methods to teach parents about dental health and encourage healthy habits for their children, focusing on using motivational techniques to help them make positive changes. The study will involve 634 pregnant women who are enrolled in the WIC program (a nutrition program for women and children) and are between 12 to 36 weeks pregnant.
To participate, you need to be a pregnant woman aged 18 to 45, able to understand and read English or Spanish, and plan to stay in the area for the next four years. Throughout the study, you'll receive supportive video messages about oral health and be followed up until your child is three years old to see if these messages lead to better dental health for your child. This trial not only hopes to reduce cavities in children but also aims to improve their overall dental care habits.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • WIC-participating pregnant women who are 18 to 45 years old
- • Between 12 and 36 weeks of the gestational period
- • Able to speak, understand and read English or Spanish
- • No intention to move away in the next 4 years
- Exclusion Criteria:
- • - Mothers who deliver their child prior to their first study intervention visit
About University Of Iowa
The University of Iowa, a leading academic and research institution, is dedicated to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university harnesses the expertise of its faculty and researchers to investigate cutting-edge therapies and treatments across various medical fields. Committed to ethical research practices and patient-centered care, the University of Iowa strives to contribute significantly to medical knowledge and improve health outcomes through rigorous scientific inquiry and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Anamosa, Iowa, United States
Belle Plaine, Iowa, United States
Cedar Rapids, Iowa, United States
Cedar Rapids, Iowa, United States
Clinton, Iowa, United States
Columbus Junction, Iowa, United States
Davenport, Iowa, United States
Davenport, Iowa, United States
De Witt, Iowa, United States
Maquoketa, Iowa, United States
Marion, Iowa, United States
Monticello, Iowa, United States
Muscatine, Iowa, United States
Tipton, Iowa, United States
Vinton, Iowa, United States
Iowa City, Iowa, United States
Patients applied
Trial Officials
Karin Weber-Gasparoni, PhD
Principal Investigator
University of Iowa
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials